Jerry Schindler has many years of experience in senior data science and biostatistics leadership roles developing drugs, biologics and devices for regulatory approval. During this time, he has been the global leader of Biostatistics, Programming, Data Management, and Clinical IT. He has led the teams involved in over 40 successful FDA advisory committee meetings and many successful regulatory submissions in the US and across the world. Dr. Schindler was one of the early advocates of adaptive clinical trials and is still involved in developing novel ways to collect and analyze high quality data quickly and efficiently. He has led the design and development of innovative IT platforms to acquire, manage, analyze and report data which has greatly accelerated the approval of new drugs. Previously, he was the Global Head of Late Development Statistics at Merck Research Laboratories, The Chief Biostatistician and Global Head of Biostatistics and Clinical Technology at Wyeth Research, and the Global Head of Enterprise Biostatistics at Medtronic. He received undergraduate and masters degrees from Georgetown University and a doctorate in Biostatistics from the University of North Carolina, Chapel Hill.